ClearPoint Neuro, Inc.
CLPT
$10.64
$0.141.33%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.14% | -11.88% | -8.28% | -12.84% | -6.32% |
| Total Depreciation and Amortization | 87.43% | -29.09% | -4.85% | 6.91% | -2.32% |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | 57.14% | -6.67% |
| Total Other Non-Cash Items | 14.87% | 11.02% | 0.53% | 32.68% | 5.67% |
| Change in Net Operating Assets | 107.56% | -248.18% | 29.84% | 887.21% | 88.84% |
| Cash from Operations | 58.65% | -396.54% | -3.67% | 55.06% | 30.52% |
| Capital Expenditure | 50.27% | 30.42% | -2,091.67% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 50.27% | 30.42% | -2,091.67% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | 17,052.38% | -82.64% | -- | -100.00% | -98.22% |
| Repurchase of Common Stock | 72.72% | -1,453.57% | -37.70% | 52.34% | 15.23% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 200.00% | -- | -- | -- | -- |
| Cash from Financing | 2,447.80% | -3,781.08% | 100.37% | -6,388.13% | -99.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 480.12% | -425.32% | 86.97% | -349.44% | -120.54% |